Evidence map›Paper›PMID 38951508›Full record

ArticleNature communications2024

Zero-dimensional halide hybrid bulk glass exhibiting reversible photochromic ultralong phosphorescence.

Fei Nie, Dongpeng Yan

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Excitation-Selective Hydrochromic Upconversion in Zero-Dimensional Metal Halides.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Quartz-Like Supramolecular Glass Enabled by Host-Guest Size Mismatch.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  5. Near-unity near-infrared emission from MoNature communications · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fei NieBeijing Key Laboratory of Energy Conversion and Storage Materials, and Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, P. R. China.
Dongpeng YanBeijing Key Laboratory of Energy Conversion and Storage Materials, and Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, P. R. China. yandp@bnu.edu.cn.ORCID http://orcid.org/0000-0001-8261-154X

Funding

Beijing Nova Program 20230484414National Natural Science Foundation of China (National Science Foundation of China) 22275021Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) L234064
6 · The paper itself

Abstract

Dynamically responsive materials, capable of reversible changes in color appearance and/or photoemission upon external stimuli, have attracted substantial attention across various fields. This study presents an effective approach wherein switchable modulation of photochromism and ultralong phosphorescence can be achieved simultaneously in a zero-dimensional organic-inorganic halide hybrid glass doped with 4,4´-bipyridine. The facile fabrication of large-scale glasses is accomplished through a combined grinding-melting-quenching process. The persistent luminescence can be regulated through the photochromic switch induced by photo-generated radicals. Furthermore, the incorporation of the aggregation-induced chirality effect generates intriguing circularly polarized luminescence, with an optical dissymmetry factor (g

Identifiers

PMID38951508
PMCPMC11217438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.